Predicting Clinical Sensitivities of <i>PDGFRA</i> Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment

Homma M. Khosroyani, Alina Teuber, Ajia Town, Lillian R. Klug, Denisse Evans, Jerry Call, Sara Rothschild, Neeta Somaiah, Prapassorn Thirasastr, Mengyuan Liu, Ping Chi, Peter Hohenberger, Piotr Rutkowski, Patrick Schöffski, Abbas Agaimy, Mehdi Brahmi, Jonathan K. Killian, Garrett M. Frampton, Carol Beadling, Sebastian Bauer, Johanna Falkenhorst, Michael C. Heinrich

Open source

DOI: 10.1158/2767-9764.crc-26-0093
Published: 2026-07-01
Container: Cancer Research Communications
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-26-0093,
  title = {Predicting Clinical Sensitivities of
                    <i>PDGFRA</i>
                    Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment},
  author = {Homma M. Khosroyani and Alina Teuber and Ajia Town and Lillian R. Klug and Denisse Evans and Jerry Call and Sara Rothschild and Neeta Somaiah and Prapassorn Thirasastr and Mengyuan Liu and Ping Chi and Peter Hohenberger and Piotr Rutkowski and Patrick Schöffski and Abbas Agaimy and Mehdi Brahmi and Jonathan K. Killian and Garrett M. Frampton and Carol Beadling and Sebastian Bauer and Johanna Falkenhorst and Michael C. Heinrich},
  year = {2026},
  journal = {Cancer Research Communications},
  doi = {10.1158/2767-9764.crc-26-0093},
  url = {https://doi.org/10.1158/2767-9764.crc-26-0093}
}

RIS

TY  - JOUR
TI  - Predicting Clinical Sensitivities of
                    <i>PDGFRA</i>
                    Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment
AU  - Homma M. Khosroyani
AU  - Alina Teuber
AU  - Ajia Town
AU  - Lillian R. Klug
AU  - Denisse Evans
AU  - Jerry Call
AU  - Sara Rothschild
AU  - Neeta Somaiah
AU  - Prapassorn Thirasastr
AU  - Mengyuan Liu
AU  - Ping Chi
AU  - Peter Hohenberger
AU  - Piotr Rutkowski
AU  - Patrick Schöffski
AU  - Abbas Agaimy
AU  - Mehdi Brahmi
AU  - Jonathan K. Killian
AU  - Garrett M. Frampton
AU  - Carol Beadling
AU  - Sebastian Bauer
AU  - Johanna Falkenhorst
AU  - Michael C. Heinrich
PY  - 2026
JO  - Cancer Research Communications
DO  - 10.1158/2767-9764.crc-26-0093
UR  - https://doi.org/10.1158/2767-9764.crc-26-0093
ER  -

APA

Khosroyani, H. M., Teuber, A., Town, A., Klug, L. R., Evans, D., Call, J., Rothschild, S., Somaiah, N., Thirasastr, P., Liu, M., Chi, P., Hohenberger, P., Rutkowski, P., Schöffski, P., Agaimy, A., Brahmi, M., Killian, J. K., Frampton, G. M., Beadling, C., Bauer, S., Falkenhorst, J., & Heinrich, M. C. (2026). Predicting Clinical Sensitivities of <i>PDGFRA</i> Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment. Cancer Research Communications. https://doi.org/10.1158/2767-9764.crc-26-0093

Source records

crossref · retrieved 2026-09-26T09:45:53.081Z